BioTech 365

MARCH 12, 2021

Amring Pharmaceuticals Inc. Enters into License and Development Agreement with Amzell B.V. Amring Pharmaceuticals Inc. Enters into License and Development Agreement with Amzell B.V. –(BUSINESS WIRE)–Amring Pharmaceuticals Inc. BERWYN, Pa.–(BUSINESS

Licensing 52

Licensing Licensing Generic Pharmaceutical Development 52

Pharma in Brief

DECEMBER 3, 2023

The original Regulations came into force on March 12, 1993, alongside changes to the Patent Act that abolished compulsory licenses for medicines and created an early-working exception to patent infringement. Evolution of the Regulations Coming into force (1993–1997). Frequent amendments (1998–2016).

Regulation 52

Regulation Compliance Medicine Manufacturing 52

XTalks

AUGUST 2, 2023

Late in 2022, AbbVie partnered with HotSpot Therapeutics and announced an exclusive worldwide collaboration and option to license agreement for their interferon regulatory factor 5 (IRF5) inhibitor program for autoimmune disease treatment. In 2022, the FDA proceeded to grant official licensing for Moderna’s Spikevax COVID-19 vaccine.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

DECEMBER 23, 2020

Under the signed license agreement, Aurobindo Pharma has obtained the exclusive rights to commercialize in India and to UNICEF and non-exclusive rights in other select emerging and developing markets. Partnering with top-tier organizations such as Aurobindo is a crucial step in expanding our global scale, reach and impact.”.

Vaccination 52

Vaccination Vaccine Manufacturing Antibody 52

The Pharma Data

DECEMBER 23, 2020

Aurobindo Pharma Limited (NSE: AUROPHARMA) (BSE: 524804) (Reuters: ARBN.NS) (Bloomberg: ARBP:IN), headquartered at Hyderabad, India , manufactures generic pharmaceuticals and active pharmaceutical ingredients. ” About Aurobindo Pharma.

Vaccination 52

Vaccination Vaccine Development Manufacturing 52